Intech Investment Management LLC Grows Stock Position in UnitedHealth Group Incorporated $UNH

by · The Cerbat Gem

Intech Investment Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 74.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 92,073 shares of the healthcare conglomerate’s stock after buying an additional 39,151 shares during the period. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $30,394,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Foundations Investment Advisors LLC raised its position in UnitedHealth Group by 9.7% in the 4th quarter. Foundations Investment Advisors LLC now owns 19,033 shares of the healthcare conglomerate’s stock worth $6,283,000 after purchasing an additional 1,678 shares during the period. Godfrey Financial Associates Inc. purchased a new stake in UnitedHealth Group in the 4th quarter worth about $40,000. Thoroughbred Financial Services LLC grew its stake in UnitedHealth Group by 4.8% in the 4th quarter. Thoroughbred Financial Services LLC now owns 6,675 shares of the healthcare conglomerate’s stock worth $2,203,000 after acquiring an additional 303 shares in the last quarter. Murphy & Mullick Capital Management Corp grew its stake in UnitedHealth Group by 18.7% in the 4th quarter. Murphy & Mullick Capital Management Corp now owns 2,431 shares of the healthcare conglomerate’s stock worth $802,000 after acquiring an additional 383 shares in the last quarter. Finally, Arista Wealth Management LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $397,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

  • Positive Sentiment: Bernstein raised its price target on UnitedHealth Group (UNH) to $492 from $444 and reiterated an Outperform rating, citing an EPS recovery outlook and implying meaningful upside. Article Title
  • Positive Sentiment: Bernstein also maintained its bullish stance after UnitedHealth’s new, more transparent PBM model, suggesting the move could improve clarity, reliability, and cost competitiveness for the company’s Optum Rx business. Article Title
  • Positive Sentiment: Coverage from Zacks and other market watchers says UNH is one of the most-tracked stocks right now, which can keep attention on the name and support sentiment if investors expect more upside. Article Title
  • Neutral Sentiment: Articles comparing UnitedHealth with Molina highlight that Molina’s Medicaid exposure and share gains currently look more attractive to some analysts, but these pieces are more relative-value commentary than a direct negative catalyst for UNH. Article Title
  • Neutral Sentiment: Seeking Alpha commentary on a possible dividend hike adds a shareholder-return angle, but it does not appear to be based on a confirmed corporate action yet. Article Title
  • Neutral Sentiment: Recent “trending stock” and “bull case” articles suggest investors are reassessing UNH’s outlook, but they are largely opinion pieces rather than new fundamental developments. Article Title

Analysts Set New Price Targets

A number of equities analysts have commented on UNH shares. Raymond James Financial upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 target price on the stock in a research note on Wednesday, April 1st. Mizuho upped their target price on shares of UnitedHealth Group from $410.00 to $440.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 20th. Oppenheimer upped their target price on shares of UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $375.00 to $395.00 and gave the company an “overweight” rating in a research note on Wednesday, April 22nd. Finally, Jefferies Financial Group increased their price objective on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research note on Monday, April 20th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.63.

Check Out Our Latest Research Report on UNH

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.28% of the stock is owned by insiders.

UnitedHealth Group Trading Down 0.5%

NYSE:UNH opened at $382.28 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $404.15. The firm has a 50 day moving average of $334.93 and a 200 day moving average of $321.14. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $347.16 billion, a price-to-earnings ratio of 28.87, a PEG ratio of 1.66 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter in the prior year, the company posted $7.20 earnings per share. UnitedHealth Group’s revenue for the quarter was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).